EA200801629A1 - Применение солей тиотропия для лечения персистирующей астмы средней тяжести - Google Patents

Применение солей тиотропия для лечения персистирующей астмы средней тяжести

Info

Publication number
EA200801629A1
EA200801629A1 EA200801629A EA200801629A EA200801629A1 EA 200801629 A1 EA200801629 A1 EA 200801629A1 EA 200801629 A EA200801629 A EA 200801629A EA 200801629 A EA200801629 A EA 200801629A EA 200801629 A1 EA200801629 A1 EA 200801629A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
salts
tiotropy
application
persistent asthma
Prior art date
Application number
EA200801629A
Other languages
English (en)
Other versions
EA015353B1 (ru
Inventor
Михаэль Энгель
Штефан Хайнрихс
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200801629(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA200801629A1 publication Critical patent/EA200801629A1/ru
Publication of EA015353B1 publication Critical patent/EA015353B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

В заявке описано применение солей тиотропия для приготовления лекарственного средства, предназначенного для лечения пациентов, страдающих персистирующей астмой средней тяжести.
EA200801629A 2006-01-04 2006-12-22 Применение солей тиотропия для лечения персистирующей астмы средней тяжести EA015353B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04
PCT/EP2006/070135 WO2007077162A1 (en) 2006-01-04 2006-12-22 Use of tiotropium salts in the treatment of moderate persistent asthma

Publications (2)

Publication Number Publication Date
EA200801629A1 true EA200801629A1 (ru) 2008-12-30
EA015353B1 EA015353B1 (ru) 2011-06-30

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801629A EA015353B1 (ru) 2006-01-04 2006-12-22 Применение солей тиотропия для лечения персистирующей астмы средней тяжести

Country Status (30)

Country Link
US (2) US20070155773A1 (ru)
EP (1) EP1971332B1 (ru)
JP (1) JP2009525950A (ru)
KR (1) KR20080083060A (ru)
CN (1) CN101355937A (ru)
AR (1) AR059126A1 (ru)
AT (1) ATE500825T1 (ru)
AU (1) AU2006334367B2 (ru)
BR (1) BRPI0620886A2 (ru)
CA (1) CA2634984C (ru)
CY (1) CY1111534T1 (ru)
DE (1) DE602006020620D1 (ru)
DK (1) DK1971332T3 (ru)
EA (1) EA015353B1 (ru)
EC (1) ECSP088588A (ru)
ES (1) ES2362306T3 (ru)
HR (1) HRP20110200T1 (ru)
IL (1) IL192602A (ru)
ME (1) ME01205B (ru)
MY (1) MY146362A (ru)
NO (1) NO20082439L (ru)
NZ (1) NZ570162A (ru)
PL (1) PL1971332T3 (ru)
PT (1) PT1971332E (ru)
RS (1) RS51703B (ru)
SI (1) SI1971332T1 (ru)
TW (1) TW200731976A (ru)
UA (1) UA95271C2 (ru)
WO (1) WO2007077162A1 (ru)
ZA (1) ZA200804436B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080039974A (ko) 2005-08-06 2008-05-07 베링거 인겔하임 인터내셔날 게엠베하 중증 지속성 천식의 치료에서 티오트로퓸 염의 용도
GB201321717D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
CA2425539C (en) * 2000-10-12 2007-04-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
SI1682542T1 (sl) * 2003-11-03 2010-04-30 Boehringer Ingelheim Int Nov kristaliniŽŤen anhidrat z antiholinergiŽŤno uŽŤinkovitostjo
AU2004285683C1 (en) * 2003-11-03 2011-09-08 Boehringer Ingelheim International Gmbh Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
CA2608142A1 (en) * 2005-05-10 2006-11-16 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
US7933722B2 (en) * 2005-05-20 2011-04-26 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
KR20080039974A (ko) * 2005-08-06 2008-05-07 베링거 인겔하임 인터내셔날 게엠베하 중증 지속성 천식의 치료에서 티오트로퓸 염의 용도
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения

Also Published As

Publication number Publication date
UA95271C2 (ru) 2011-07-25
ATE500825T1 (de) 2011-03-15
ECSP088588A (es) 2008-07-30
NZ570162A (en) 2011-09-30
US20150224090A1 (en) 2015-08-13
RS51703B (en) 2011-10-31
CA2634984C (en) 2014-05-06
BRPI0620886A2 (pt) 2011-11-29
CY1111534T1 (el) 2015-08-05
DE602006020620D1 (de) 2011-04-21
IL192602A (en) 2013-06-27
NO20082439L (no) 2008-08-04
AU2006334367A1 (en) 2007-07-12
EP1971332A1 (en) 2008-09-24
JP2009525950A (ja) 2009-07-16
KR20080083060A (ko) 2008-09-12
DK1971332T3 (da) 2011-04-18
TW200731976A (en) 2007-09-01
WO2007077162A1 (en) 2007-07-12
SI1971332T1 (sl) 2011-05-31
US20070155773A1 (en) 2007-07-05
EP1971332B1 (en) 2011-03-09
AR059126A1 (es) 2008-03-12
CA2634984A1 (en) 2007-07-12
PT1971332E (pt) 2011-03-18
AU2006334367B2 (en) 2012-11-08
ZA200804436B (en) 2008-12-31
HRP20110200T1 (hr) 2011-04-30
PL1971332T3 (pl) 2011-08-31
EA015353B1 (ru) 2011-06-30
IL192602A0 (en) 2009-09-22
MY146362A (en) 2012-08-15
ES2362306T3 (es) 2011-07-01
ME01205B (me) 2013-03-20
CN101355937A (zh) 2009-01-28

Similar Documents

Publication Publication Date Title
DK2233135T3 (da) Anvendelse af en betablokker til fremstilling af et medikament til behandling af hæmangiomer
MX2009007421A (es) Nucleo absorbente que tiene estructura mejorada.
MX2010001589A (es) Nucleo absorbente.
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
MX2010005983A (es) Nucleo absorbente.
AU2011274192A8 (en) Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
EA201100335A1 (ru) Производные пурина для применения при лечении связанных с fab заболеваний
ECSP12011799A (es) Compuestos de espiropiperidina y uso farmacéutico de los mismos
BRPI0922091A2 (pt) cassete cirúrgico oftálmico
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
WO2013003669A3 (en) Compositions, methods of use, and methods of treatment
AU2008233232A8 (en) Combination therapy for the treatment-of Lower Urinary Tract Symptoms
EA201171043A1 (ru) Композиции и способы длительной терапии с применением аминопиридинов
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
WO2009074247A8 (de) Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel
EA200801629A1 (ru) Применение солей тиотропия для лечения персистирующей астмы средней тяжести
WO2009144551A3 (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood
EA201071098A1 (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
WO2009018551A3 (en) Therapeutic compounds
MX2008001506A (es) Uso de sales de triotropio en el tratamiento de asma severa persistente.
SV2009003315A (es) Nueva utilizacion para el tratamiento de las leucemias
BRPI0820210A2 (pt) composto, composição farmacêutica, uso de um composto, e, método de tratamento terapêutico de um mamífero.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ